ANIXA BIOSCIENCES INC (ANIX) Stock News

USA - NASDAQ:ANIX - US03528H1095 - Common Stock

4.34 USD

-0.06 (-1.36%)

Last: 11/21/2025, 4:00:42 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ANIX Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: Anixa Biosciences, Inc.

Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization

11 days ago - By: Anixa Biosciences, Inc.

Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025

16 days ago - By: Zacks Investment Research - Mentions: BSX

Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year?

16 days ago - By: Anixa Biosciences, Inc.

Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic

a month ago - By: Anixa Biosciences, Inc.

Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference

a month ago - By: Anixa Biosciences, Inc.

Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology

a month ago - By: Zacks Investment Research

Are You Looking for a Top Momentum Pick? Why ANIXA BIOSCIENCES INC (ANIX) is a Great Choice

2 months ago - By: Zacks Investment Research - Mentions: AMRX

Are Medical Stocks Lagging Amneal Pharmaceuticals (AMRX) This Year?

2 months ago - By: Anixa Biosciences, Inc.

Cleveland Clinic to Present Final Results of Phase 1 Clinical Trial for Anixa Biosciences' Breast Cancer Vaccine at 2025 San Antonio Breast Cancer Symposium

2 months ago - By: Anixa Biosciences, Inc.

Anixa Biosciences and Moffitt Cancer Center Complete Dosing of Fourth Cohort in Ovarian Cancer CAR-T Clinical Trial; Multiple Patients Surpassing Median Expected Survival

3 months ago - By: Anixa Biosciences, Inc.

Anixa Biosciences Announces Time Change for Presentation at the H.C. Wainwright 27th Annual Global Investment Conference

3 months ago - By: Anixa Biosciences, Inc.

Anixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference

3 months ago - By: Anixa Biosciences, Inc.

Anixa Biosciences Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine Technology

3 months ago - By: Anixa Biosciences, Inc.

Anixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical Trial

3 months ago - By: Anixa Biosciences, Inc.

Anixa Biosciences Announces Issuance of Additional U.S. Patent for CAR-T Technology

4 months ago - By: Anixa Biosciences, Inc.

Anixa Biosciences Announces Dr. Robert Wenham will speak about Immunotherapy in surviving Ovarian Cancer at the 13th Annual Ovarcoming Cancer Conference

4 months ago - By: Anixa Biosciences, Inc.

Anixa Biosciences Announces Commencement of US FDA Approved IND Transfer to Support Upcoming Phase 2 Breast Cancer Vaccine Trial

5 months ago - By: Anixa Biosciences, Inc.

Anixa Biosciences to Host an Investor Webcast on June 26, 2025

5 months ago - By: Anixa Biosciences, Inc.

Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage

6 months ago - By: Zacks Investment Research

All You Need to Know About Anixa Biosciences (ANIX) Rating Upgrade to Buy

6 months ago - By: Zacks Investment Research - Mentions: CLRB

Are Medical Stocks Lagging Anixa Biosciences (ANIX) This Year?

6 months ago - By: Anixa Biosciences, Inc.

Anixa Biosciences' Breast Cancer Vaccine Featured in NewsNation Interview

6 months ago - By: Anixa Biosciences, Inc.

Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine

6 months ago - By: Anixa Biosciences, Inc.

Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting

7 months ago - By: Anixa Biosciences, Inc.

Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio

8 months ago - By: Anixa Biosciences, Inc.

Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology

8 months ago - By: Benzinga

EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent

8 months ago - By: Yahoo Finance

EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent

8 months ago - By: Benzinga - Mentions: PTIX AEMD SLRX WORX ...

12 Health Care Stocks Moving In Tuesday's After-Market Session

8 months ago - By: Anixa Biosciences, Inc.

Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th

8 months ago - By: Anixa Biosciences, Inc.

Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines